Annual report
7096.TEDINET S100R2C5
Period2022-04-01 → 2023-03-31
Filed2023-06-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 80
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.1bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥1.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥298m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥227m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥300m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥213m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥92m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥383m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥216m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥279m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥213m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥198m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥134m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥62m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥277m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥143m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.8bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥5.2bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥4.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.6bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.8bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.5bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.3bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥982m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.3bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.3bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.7bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥100m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥469m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥239m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥668m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥391m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥285m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥404m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥520m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥108m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥184m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥869,000 | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥644m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥19.33 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.2 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.41 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.51 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.67 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥224.33 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥205.33 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥135.83 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥129.42 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥100.92 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 39.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.3% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.4% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.3% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.9% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.0% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,246,600 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,123,300 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,867,100 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,867,100 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,953 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 92 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 82 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 79 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 84 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 59 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 817
| Item | Context | Value | Unit |
|---|---|---|---|
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 9690000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 9473000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-06-26 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第24期(自 2022年４月１日 至 2023年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ステムセル研究所 | |
| Company name in english cover page | FilingDateInstant | StemCell Institute Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 清水 崇文 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門一丁目21番19号（2023年５月29日から本店所在地を上記に移転しております。） | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | ０３－６８１１－３２３０ | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員管理本部長 谷 勝弘 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区虎ノ門一丁目21番19号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | ０３－６８１１－３２３５ | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員管理本部長 谷 勝弘 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E35563 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 70960 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ステムセル研究所 | |
| Filer name in english | FilingDateInstant | StemCell Institute Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |